Sulková S, Laurincová Z, Kvasnicka J
Interní oddĕlení Strahov fakultní nemocnice 2 s FP UNZ, Praha.
Cas Lek Cesk. 1990 Jan 26;129(4):113-5.
In five female patients with chronic renal failure who had regular dialyzation treatment it was revealed that hyperaluminaemia reduces the effect of erythropoietin. In view of the high cost of this drug it is reasonable to maintain the aluminium value at the lowest levels.
在五名接受定期透析治疗的慢性肾衰竭女性患者中发现，高铝血症会降低促红细胞生成素的疗效。鉴于这种药物成本高昂，将铝含量维持在最低水平是合理的。
